|
注册号: Registration number: |
ChiCTR2400093956 |
|
最近更新日期: Date of Last Refreshed on: |
2024-12-13 17:39:32 |
|
注册时间: Date of Registration: |
2024-12-13 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
低频经皮神经电刺激缓解老年人常见慢性疾病的疗效观察和机制研究 |
|
Public title: |
Effects and mechanisms of low-frequency transcutaneous electrical nerve stimulation in relieving common chronic diseases in older adults |
|
注册题目简写: |
低频TENS与老年慢病 |
|
English Acronym: |
Low-frequency TENS and chronic diseases in older adults |
|
研究课题的正式科学名称: |
低频经皮神经电刺激缓解老年人常见慢性疾病的疗效观察和机制研究 |
|
Scientific title: |
Effects and mechanisms of low-frequency transcutaneous electrical nerve stimulation in relieving common chronic diseases in older adults |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
李翔 |
研究负责人: |
李翔 |
|
Applicant: |
Li Xiang |
Study leader: |
Li Xiang |
|
申请注册联系人电话: Applicant telephone: |
+86 150 0888 7368 |
研究负责人电话:
Study leader's |
+86 150 0888 7368 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1162704105@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
1162704105@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
云南省昆明市盘龙区龙泉路871号 |
研究负责人通讯地址: |
云南省昆明市盘龙区龙泉路871号 |
|
Applicant address: |
No. 871, Longquan Road, Panlong District, Kunming City, Yunnan Province |
Study leader's address: |
No. 871, Longquan Road, Panlong District, Kunming City, Yunnan Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
昆明市第二人民医院 |
||
|
Applicant's institution: |
Kunming Second People's Hospital |
||
|
研究负责人所在单位: |
昆明市第二人民医院 |
||
|
Affiliation of the Leader: |
The Second People's Hospital of Kunming |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
202401011 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
昆明市第二人民医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Kunming Second People's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-11-22 00:00:00 | ||
|
伦理委员会联系人: |
叶渊 |
||
|
Contact Name of the ethic committee: |
Ye Yuan |
||
|
伦理委员会联系地址: |
云南省昆明市盘龙区龙泉路871号 |
||
|
Contact Address of the ethic committee: |
No. 871 Longquan Road, Panlong District, Kunming City, Yunnan Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 188 1221 2461 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
昆明市第二人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Second People's Hospital of Kunming |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
云南省昆明市盘龙区龙泉路871号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 871 Longquan Road, Panlong District, Kunming City, Yunnan Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
昆明市老年综合征康复治疗医学技术中心(2023-SW(技)-26) |
||||||||||||||||||||||
|
Source(s) of funding: |
Kunming Health Science and Technology Talent Training Project, Kunming Geriatric Syndrome Rehabilitation Treatment Medical Technology Center [No. 2023-SW (Technology)-26] . |
||||||||||||||||||||||
|
研究疾病: |
常见慢性疾病 |
||||||||||||||||||||||
|
Target disease: |
common chronic diseases |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
探究低频电刺激对老年人常见慢性疾病的疗效与作用机制 |
||||||||||||||||||||||
|
Objectives of Study: |
To investigate the effects and mechanisms of low-frequency transcutaneous electrical nerve stimulation on common chronic diseases in older adults |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1)存在电刺激治疗的禁忌症,如佩戴心脏起搏器、金属植入物、既往癫痫、肿瘤病史等; 2) 除常规使用控制慢性病的药物外,在过去2个月内使用其他影响血压、血糖和/或血脂的药物(如糖皮质激素、中枢神经系统抑制剂等); 3) 存在严重的认知或言语障碍; 4) 存在其他影响血压、血糖和/或血脂的严重疾病; 5) 在过去两个月内参与了另一项临床试验。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1) contraindications to electrical stimulation therapy, such as wearing a cardiac pacemaker, metal implants, scars, bruises, scratches or inflammation on the skin of treatment area, a previous history of epilepsy, tumor, etc; 2) except the routine pharmacy to control the multiple chronic conditions, use of other pharmacy that affect blood pressure, blood sugar, and/or lipids in the previous 2 months (glucocorticoids, central nervous system inhibitors, etc.); 3) severe cognitive or speech impairment; 4) other serious illnesses that influenced blood pressure, blood sugar, and/or lipids; 5) participation in another clinical trial within the past two months. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-12-16 00:00:00至 To 2025-06-15 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-12-23 00:00:00 至 To 2025-05-16 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
研究负责人将利用在线随机化工具(www.random.org)创建随机序列 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The principal investigator will use an online randomization tool (www.random. org) to create the random sequence. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
对评估人员设盲 |
|
Blinding: |
Blinding the assessor |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2026年12月31日之前公布于中国临床试验注册中心平台。数据公开方式将采用ResMan (http://www.medresman.org.cn/)。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Announced on the Chinese Clinical Trial Registry platform before December 31, 2026. The data disclosure method will adopt ResMan( http://www.medresman.org.cn/ ). |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集由本项目组内研究人员(非试验操作者)进行采集,形成纸质版评估表,再上传至电子采集与管理系统(Excel)。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The data collection is carried out by researchers (non experimental operators) within the project team, forming a paper version of the evaluation form, and then uploading it to the electronic collection and management system (Excel). |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |